SCHEMBL3889231

SCHEMBL3889231

CC(=O)Oc1ccc(C(O)CNCCCCCOCCOCc2c(Cl)cccc2Cl)cc1CO

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 20/20 0.77
ADRB1 P08588 15/20 0.77
ADRB3 P13945 15/20 0.77
MLNR O43193 1/20 0.73
NR1I2 O75469 1/20 0.73
ABCB11 O95342 1/20 0.73
ADORA3 P0DMS8 1/20 0.73
DRD1 P21728 1/20 0.73
SLC6A2 P23975 1/20 0.73
HTR2A P28223 1/20 0.73
SLC6A4 P31645 1/20 0.73
ADRA1A P35348 1/20 0.73
PTGS2 P35354 1/20 0.73
MC3R P41968 1/20 0.73
SLC6A3 Q01959 1/20 0.73
PDE4D Q08499 1/20 0.73
SCN5A Q14524 1/20 0.73
GHSR Q92847 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL925231 1.00 ADRB2 (0.77) ADRB2ADRB1ADRB3MLNRNR1I2
SCHEMBL925232 1.00 ADRB2 (0.77) ADRB2ADRB1ADRB3MLNRNR1I2
SCHEMBL927369 0.87 ADRB2 (0.77) ADRB2ADRB1ADRB3MLNRNR1I2
SCHEMBL925567 0.87 ADRB2 (0.67) ADRB2ADRB1ADRB3MLNRNR1I2
SCHEMBL3844771 0.87 ADRB2 (0.77) ADRB2ADRB1ADRB3MLNRNR1I2
SCHEMBL164421 0.87 ADRB2 (0.68) ADRB2ADRB1ADRB3MLNRNR1I2
SCHEMBL29515412 0.87 ADRB2 (0.68) ADRB2ADRB1ADRB3MLNRNR1I2
SCHEMBL20659853 0.87 ADRB2 (0.68) ADRB2ADRB1ADRB3MLNRNR1I2
Acetic Acid SCHEMBL925230 0.87 ADRB2 (1.00) ADRB2ADRB1ADRB3MLNRNR1I2
Vilanterol SCHEMBL925229 0.87 ADRB2 (1.00) ADRB2ADRB1ADRB3MLNRNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2042168-A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases Glaxo Group Limited (GB) 2009-04-01 EP disclosed